We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




AI Camera Technology Helps Doctors Quickly Assess Severity of Infections

By HospiMedica International staff writers
Posted on 11 Jun 2024

A significant number of patients who visit healthcare centers are seeking help for symptoms like sore throats, coughs, and fever. More...

While many of these infections are harmless and self-resolving, they can sometimes be the initial signs of more severe and potentially life-threatening illnesses such as pneumonia, COVID-19, and Lemierre’s syndrome. It is crucial to quickly evaluate the severity of these symptoms to provide necessary treatment without the inappropriate use of antibiotics. The overuse of antibiotics leads to the development of resistant bacteria strains, diminishing the effectiveness of these drugs. Currently, the severity of an infection is determined by checking vital signs, which are key indicators of a person's physical health, using a variety of instruments. Now, a new technology that can measure a patient’s pulse, breathing, and blood pressure simply by scanning their face could provide a tool for quickly assessing the severity of acute infection and other medical conditions.

The newly developed method by researchers at the University of Gothenburg (Gothenburg, Sweden) combines camera technology, software, and artificial intelligence (AI) to potentially replicate the results obtained from traditional instruments by simply scanning a patient's face for 30 seconds. In a recent study involving over 200 patients suspected of having COVID-19, this camera-based method was clinically tested and shown to enhance both the assessment of severity and the accuracy of diagnoses. The technology was able to provide data on the patient’s heart rate, oxygen saturation, respiratory rate, and blood pressure. Although the findings are promising, they require further validation, particularly concerning the precision of the measurements.

“The new AI method means that measurements are faster, more convenient for the patient, easier for the healthcare provider, and involve less risk of infections being spread via measuring equipment,” said Stefan Malmberg from the University of Gothenburg. “This type of research is crucial for the development of new healthcare technologies.”

Related Links:
University of Gothenburg


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Trocar
TAN RoTaLock Trocar
New
High Pressure Balloon Catheter
UroMax Ultra
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: For the first time, a fluorescent-guided nerve imaging agent has shown promise for use in humans (Photo courtesy of VUMC)

Fluorescent Imaging Agent ‘Lights Up’ Nerves for Better Visualization During Surgery

Surgical nerve injury is a significant concern in head and neck surgeries, where nerves are at risk of being inadvertently damaged during procedures. Such injuries can lead to complications that may impact... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.